Are you a busy veterinarian looking to stay up to date on the latest developments in canine lymphoma management? Then don't miss our informative and engaging presentation on the subject. We'll cover the chemotherapy sensitivity predictor, a diagnostic technique that can help guide treatment decisions, as well as prognostic factors, and the latest treatment options, including the exciting new drugs Tanovea and Laverdia. You'll also learn about survival times with and without chemotherapy, as well as supportive care options when treatment is declined. Join us for an essential update on the diagnosis and management of this complex disease and go beyond prednisone in your treatment approaches for canine lymphoma.
.jpg "Sue Ettinger, DVM, DACVIM (Oncology) photo")